Process for the preparation of darunavir
OwnerSiva Rama Prasad Vellanki, Arabinda Sahu +5inventors
InventorsSiva Rama Prasad Vellanki, Arabinda Sahu, Aravind Kumar Katukuri, Vikram Vanama, Satishbabu Kothari, Venkata Suryanarayana Ponnekanti, Debashish Datta
Life of this patent
Estimating the term…
Abstract
A process for the preparation of Darunavir comprises the reacting of 4-amino-N-(2R,3S) (3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-benzenesulfonamide with (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol derivative in N-methyl-2-pyrrolidinone and isolating the resulting Darunavir. The process yields Darunavir with a very low level of the difuranyl impurity.
Claims13
-23. (canceled)
A process for the preparation of amorphous Darunavir containing less than 0.1% of the difuranyl impurity comprising the steps of:
- a) coupling the compound of formula 4 with (3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-01 derivative (5) in a solvent to obtain Darunavir,
- b) optionally converting the Darunavir to Darunavir solvate,
- c) dissolving the Darunavir or Darunavir solvate in a solvent, and
- d) isolating amorphous Darunavir.
A process for the preparation of Darunavir containing less than 0.1% of the difuranyl impurity, comprising coupling the compound of formula 4 with (3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-ol derivative (5) in N-methyl-2 pyrrolidinone (NMPO)
A process for the preparation of amorphous Darunavir comprising the steps of:
- a) dissolving Darunavir in an organic solvent,
- b) removing the solvent,
- c) optionally adding a hydrocarbon solvent, and
- d) isolating amorphous Darunavir.
Darunavir ethanolate or amorphous Darunavir having a purity of more than 99.5% and containing less than 0.08% of the difuranyl impurity.
A process for the preparation of amorphous Darunavir, which comprises:
- a) providing a solution, suspension or dispersion of Darunavir or Darunavir solvate, either alone or in combination with one or more pharmaceutically acceptable carriers, in a solvent;
- and
- b) removing the solvent from the solution to provide the desired amorphous Darunavir.
A pharmaceutical composition of amorphous Darunavir or the pharmaceutically acceptable salt or solvate thereof containing less than 0.1% of the difuranyl impurity.
Dependencies are inferred from the claim text.